Study limitation: Seven participants were concurrently using incretin-based therapies (e.g., GLP-1 agonists); post hoc subgroup results are pending a separate publication | ReachRx
A 6-Month Prospective, Open-Label, Randomized Study Showing Increased Hair Growth Rate in Women Using Multi-Targeting Hair Growth Nutraceuticals
Study limitation reported by the research below: “Seven participants were concurrently using incretin-based therapies (e.g., GLP-1 agonists); post hoc subgroup results are pending a separate publication.”
